| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1111/J.0105-2896.2006.00406.X |
| P8608 | Fatcat ID | release_wnycbuzfrvauhjlaqk5d7zbbca |
| P698 | PubMed publication ID | 16903922 |
| P5875 | ResearchGate publication ID | 6883341 |
| P50 | author | Herman Waldmann | Q5740316 |
| Stephen P. Cobbold | Q42428601 | ||
| P2093 | author name string | Elizabeth Adams | |
| Paul Fairchild | |||
| P2860 | cites work | Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance | Q44620458 |
| Modulation of tryptophan catabolism by regulatory T cells. | Q44632333 | ||
| Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase | Q45047397 | ||
| Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants | Q47644499 | ||
| Generation of anergic and regulatory T cells following prolonged exposure to a harmless antigen | Q47644661 | ||
| Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. | Q47726082 | ||
| Exploiting tolerance processes in transplantation. | Q53637597 | ||
| Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. | Q53883439 | ||
| Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 | ||
| Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
| Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells | Q28513895 | ||
| TGF beta 1 inhibits Ca2+-calcineurin-mediated activation in thymocytes | Q28594881 | ||
| Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor | Q28595009 | ||
| Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival | Q29547865 | ||
| A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 | ||
| CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production | Q29619536 | ||
| Regulatory T cells overexpress a subset of Th2 gene transcripts | Q31035510 | ||
| Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms | Q33195020 | ||
| Actively acquired tolerance of foreign cells | Q34233179 | ||
| The role of CD4+ T-cell subsets in determining transplantation rejection or tolerance | Q34448471 | ||
| Identification of regulatory T cells in tolerated allografts | Q34524237 | ||
| In vivo instruction of suppressor commitment in naive T cells | Q34548023 | ||
| Reprogramming the immune system | Q34792489 | ||
| On cross-priming of MHC class I-specific CTL: rule or exception? | Q34807760 | ||
| Regulatory T cells in transplantation tolerance | Q35092535 | ||
| Generation and function of antigen-specific suppressor and regulatory T cells | Q35216458 | ||
| Serial analysis of gene expression provides new insights into regulatory T cells | Q35613442 | ||
| Regulatory T cells and organ transplantation | Q35703532 | ||
| Monoclonal antibodies as agents to reinduce tolerance in autoimmunity. | Q35703967 | ||
| Homeostasis and T cell regulation | Q35931574 | ||
| Donor-specific transplantation tolerance: the paradoxical behavior of CD4+CD25+ T cells | Q35971446 | ||
| Regulatory T cells and intestinal homeostasis | Q36079900 | ||
| Regulatory T cells in immunologic self-tolerance and autoimmune disease | Q36203567 | ||
| Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells | Q36351226 | ||
| T cell regulation as a side effect of homeostasis and competition | Q36370619 | ||
| CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice | Q36399304 | ||
| Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression | Q40558786 | ||
| A repressor of GATA-mediated negative feedback mechanism of T cell activation | Q40605258 | ||
| Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. | Q41326954 | ||
| Induction of classical transplantation tolerance in the adult | Q41965507 | ||
| IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo | Q42971329 | ||
| Induction of tolerance by monoclonal antibody therapy | Q43419298 | ||
| Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. | Q44539418 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 301-313 | |
| P577 | publication date | 2006-08-01 | |
| P1433 | published in | Immunological Reviews | Q15724582 |
| P1476 | title | Infectious tolerance and the long-term acceptance of transplanted tissue | |
| P478 | volume | 212 |
| Q46669152 | 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters the differentiation of alloreactive CD8+ T cells toward a regulatory T cell phenotype by a mechanism that is dependent on aryl hydrocarbon receptor in CD4+ T cells |
| Q38922184 | A Novel Model on DST-Induced Transplantation Tolerance by the Transfer of Self-Specific Donor tTregs to a Haplotype-Matched Organ Recipient |
| Q43103019 | A Small Molecule β2 Integrin Agonist Improves Chronic Kidney Allograft Survival by Reducing Leukocyte Recruitment and Accompanying Vasculopathy |
| Q81157115 | A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells |
| Q40132561 | Adoptive T Regulatory Cell Therapy for Tolerance Induction |
| Q42057025 | Antigen-based therapy for the treatment of type 1 diabetes |
| Q41815808 | Apoptotic cell-linked immunoregulation: implications for promoting immune tolerance in transplantation |
| Q46196228 | Bioavailability of Sandimmun® versus Sandimmun Neoral®: a meta-analysis of published studies |
| Q46763767 | CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H. |
| Q30491507 | CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy-treated hemophilia mice |
| Q35927387 | CD4-blockade can induce protection from peanut-induced anaphylaxis |
| Q38063958 | CD73 and adenosine generation in the creation of regulatory microenvironments. |
| Q45834735 | Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. |
| Q24650734 | Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction |
| Q53229165 | Characterisation of Tertiary Lymphoid Organs in Explanted Rejected Donor Kidneys. |
| Q41876934 | Combining Treg therapy with mixed chimerism: Getting the best of both worlds |
| Q35117339 | Control of the differentiation of regulatory T cells and T(H)17 cells by the DNA-binding inhibitor Id3. |
| Q37661374 | Cross-immune tolerance: conception and its potential significance on transplantation tolerance |
| Q34629201 | Cutting edge: Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance |
| Q52856887 | Cytokines affecting CD4+T regulatory cells in transplant tolerance. III. Interleukin-5 (IL-5) promotes survival of alloantigen-specific CD4+ T regulatory cells. |
| Q46961808 | Deacetylase inhibition promotes the generation and function of regulatory T cells. |
| Q36228938 | Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice |
| Q37786736 | Developmental plasticity of Foxp3+ regulatory T cells |
| Q60614966 | Differential kinetics of effector and regulatory T cells in patients on calcineurin inhibitor–based drug regimens |
| Q40309811 | Distinct strategies are required to suppress antigen-specific responses to genetically modified keratinocytes and fibroblasts |
| Q50630554 | Evaluation of CD4+ CD25+/- CD39+ T-cell populations in peripheral blood of patients following kidney transplantation and during acute allograft rejection. |
| Q36304690 | Forkhead-box transcription factor 1 affects the apoptosis of natural regulatory T cells by controlling Aven expression |
| Q42941731 | GITR Blockade Facilitates Treg Mediated Allograft Survival |
| Q40055892 | Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3. |
| Q37100901 | Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity |
| Q34631825 | How tolerogenic dendritic cells induce regulatory T cells |
| Q34432872 | IL-35-mediated induction of a potent regulatory T cell population. |
| Q37349741 | Immune privilege or privileged immunity? |
| Q84547719 | Immune responses against islet allografts during tapering of immunosuppression--a pilot study in 5 subjects |
| Q33907609 | Immune tolerance induction by integrating innate and adaptive immune regulators |
| Q37026155 | Immunologic Monitoring of T-Lymphocyte Subsets and Hla-Dr-Positive Monocytes in Kidney Transplant Recipients: A Prospective, Observational Cohort Study. |
| Q37472002 | In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance |
| Q38032201 | Indoleamine 2,3-dioxygenase: from catalyst to signaling function |
| Q36843741 | Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies? |
| Q38005241 | Key cellular components and interactive histocompatibility molecules regulating tolerance to the fetal allograft. |
| Q33743988 | Lethal effect of CD3-specific antibody in mice deficient in TGF-beta1 by uncontrolled flu-like syndrome |
| Q34661115 | Lineage stability and phenotypic plasticity of Foxp3⁺ regulatory T cells. |
| Q37941742 | Matchmaking the B-cell signature of tolerance to regulatory B cells |
| Q37422767 | Modalities and future prospects of gene therapy in heart transplantation |
| Q36883762 | Myeloid dendritic cells isolated from tissues of SIV-infected Rhesus macaques promote the induction of regulatory T cells |
| Q37366061 | Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells |
| Q36338254 | Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment |
| Q34100538 | Nutrient Sensing via mTOR in T Cells Maintains a Tolerogenic Microenvironment |
| Q42657479 | Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine. |
| Q37319391 | Privilege revisited: an evaluation of the eye's defence mechanisms |
| Q53530470 | Regulation and privilege in transplantation tolerance. |
| Q88777827 | Regulatory T Cells and Kidney Transplantation |
| Q36986732 | Regulatory T cells - a brief history and perspective |
| Q37900645 | Regulatory T cells and IL-17-producing cells in graft-versus-host disease |
| Q34966662 | Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. |
| Q37855952 | Regulatory T-cell adoptive immunotherapy: potential for treatment of autoimmunity |
| Q36891917 | Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. |
| Q37302327 | Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? |
| Q33850088 | Regulatory ripples |
| Q38027504 | Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation. |
| Q64230014 | Reprogrammed CD4 T Cells That Express FoxP3 Control Inhibitory Antibody Formation in Hemophilia A Mice |
| Q36954616 | Skin tolerance: in search of the Holy Grail. |
| Q37043725 | Special regulatory T-cell review: A rose by any other name: from suppressor T cells to Tregs, approbation to unbridled enthusiasm |
| Q64072336 | Strategies for the Induction of Immune Tolerance to Enzyme Replacement Therapy in Mucopolysaccharidosis Type I |
| Q36398678 | Strategies to circumvent humoral immunity to adeno-associated viral vectors |
| Q36479748 | Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine |
| Q59130097 | T cell Allorecognition Pathways in Solid Organ Transplantation |
| Q33999342 | TGF-beta and 'adaptive' Foxp3(+) regulatory T cells |
| Q83014796 | Tertiary lymphoid organs in renal allografts can be associated with donor-specific tolerance rather than rejection |
| Q35962634 | The battle against immunopathology: infectious tolerance mediated by regulatory T cells |
| Q43042641 | The calcineurin inhibitor tacrolimus allows the induction of functional CD4CD25 regulatory T cells by rabbit anti-thymocyte globulins. |
| Q26830354 | The mTOR pathway and integrating immune regulation |
| Q36747499 | The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease |
| Q64065212 | Therapeutic Potential of Regulatory T Cells in Preeclampsia-Opportunities and Challenges |
| Q36959215 | Thymic versus induced regulatory T cells - who regulates the regulators? |
| Q38039091 | Translating tolerogenic therapies to the clinic - where do we stand? |
| Q35107006 | Transplantation tolerance: Clinical potential of regulatory T cells |
| Q34082059 | Transplantation tolerance: from theory to clinic |
| Q47121682 | Update on Dendritic Cell-Induced Immunological and Clinical Tolerance. |
Search more.